Sfoglia per Autore
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome
2009-01-01 Koster, Mi; Marinari, B; Payne, As; Kantaputra, Pn; Costanzo, A; Roop, Dr
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
2009-01-01 Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S
Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study
2009-01-01 Mazzotta, A; Esposito, M; Costanzo, A; Chimenti, S
Different applications of monochromatic excimer light in skin diseases
2009-01-01 Nistico', Sp; Saraceno, R; Schipani, C; Costanzo, A; Chimenti, S
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation
2009-04-15 Moretti, F; Costanzo, A
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain
2009-10-15 Muscolini, M; Montagni, E; Caristi, S; Nomura, T; Kamada, R; Di Agostino, S; Corazzari, M; Piacentini, M; Blandino, G; Costanzo, A; Sakaguchi, K; Tuosto, L
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting
2009-11-01 Lunghi, P; Costanzo, A; Mazzera, L; Rizzoli, V; Levrero, M; Bonati, A
Pathogenic role of interleukin-21 in psoriasis
2009-11-15 Caruso, R; Costanzo, A; Monteleone, G
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab
2010-01-01 Papoutsaki, M; Talamonti, M; Giunta, A; Costanzo, A; Ruzzetti, M; Teoli, M; Chimenti, S
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas
2010-01-01 Costanzo, A; Spallone, G; Karin, M
Treasure or artifact: a decade of p63 research speaks for itself
2010-01-01 Mikkola, M; Costanzo, A; Thesleff, I; Roop, D; Koster, M
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010-05-03 Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A
IL-21 in the pathogenesis and treatment of skin diseases
2010-11-01 Costanzo, A; Chimenti, Ms; Botti, E; Caruso, R; Sarra, M; Monteleone, G
Elementi di dermatologia
2011-01-01 Carboni, I; Nisticò, S; Costanzo, A; Bianchi, L
Efalizumab
2011-01-01 Talamonti, M; Spallone, G; Di Stefani, A; Costanzo, A; Chimenti, S
Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
2011-01-01 Talamonti, M; Galluzzo, M; Teoli, M; Bavetta, M; Chimenti, S; Costanzo, A
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia
2011-01-01 Sarra, M; Caruso, R; Cupi, M; Monteleone, I; Stolfi, C; Costanzo, A; Campione, E; Pallone, F; Diluvio, L; Mazzotta, A; Botti, E; Chimenti, S; Costanzo, A; Macdonald, T; Pallone, F; Monteleone, G
Psoriasis: from pathogenesis to novel therapeutic approaches
2011-01-01 Monteleone, G; Pallone, F; Macdonald, T; Chimenti, S; Costanzo, A
Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome
2012-01-01 Talamonti, M; Galluzzo, M; Chiricozzi, A; Teoli, M; Bavetta, M; Costanzo, A; Chimenti, S
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2009 | Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome | Koster, Mi; Marinari, B; Payne, As; Kantaputra, Pn; Costanzo, A; Roop, Dr | Articolo su rivista | |
1-gen-2009 | Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy | Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study | Mazzotta, A; Esposito, M; Costanzo, A; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Different applications of monochromatic excimer light in skin diseases | Nistico', Sp; Saraceno, R; Schipani, C; Costanzo, A; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
15-apr-2009 | A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation | Moretti, F; Costanzo, A | Articolo su rivista | |
15-ott-2009 | Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain | Muscolini, M; Montagni, E; Caristi, S; Nomura, T; Kamada, R; Di Agostino, S; Corazzari, M; Piacentini, M; Blandino, G; Costanzo, A; Sakaguchi, K; Tuosto, L | Articolo su rivista | |
1-nov-2009 | The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting | Lunghi, P; Costanzo, A; Mazzera, L; Rizzoli, V; Levrero, M; Bonati, A | Articolo su rivista | |
15-nov-2009 | Pathogenic role of interleukin-21 in psoriasis | Caruso, R; Costanzo, A; Monteleone, G | Articolo su rivista | |
1-gen-2010 | The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab | Papoutsaki, M; Talamonti, M; Giunta, A; Costanzo, A; Ruzzetti, M; Teoli, M; Chimenti, S | Articolo su rivista | |
1-gen-2010 | NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas | Costanzo, A; Spallone, G; Karin, M | Contributo in libro | |
1-gen-2010 | Treasure or artifact: a decade of p63 research speaks for itself | Mikkola, M; Costanzo, A; Thesleff, I; Roop, D; Koster, M | Articolo su rivista | |
3-mag-2010 | A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias | Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-nov-2010 | IL-21 in the pathogenesis and treatment of skin diseases | Costanzo, A; Chimenti, Ms; Botti, E; Caruso, R; Sarra, M; Monteleone, G | Articolo su rivista | |
1-gen-2011 | Elementi di dermatologia | Carboni, I; Nisticò, S; Costanzo, A; Bianchi, L | Monografia | |
1-gen-2011 | Efalizumab | Talamonti, M; Spallone, G; Di Stefani, A; Costanzo, A; Chimenti, S | Articolo su rivista | |
1-gen-2011 | Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis | Talamonti, M; Galluzzo, M; Teoli, M; Bavetta, M; Chimenti, S; Costanzo, A | Intervento a convegno | |
1-gen-2011 | IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia | Sarra, M; Caruso, R; Cupi, M; Monteleone, I; Stolfi, C; Costanzo, A; Campione, E; Pallone, F; Diluvio, L; Mazzotta, A; Botti, E; Chimenti, S; Costanzo, A; Macdonald, T; Pallone, F; Monteleone, G | Articolo su rivista | |
1-gen-2011 | Psoriasis: from pathogenesis to novel therapeutic approaches | Monteleone, G; Pallone, F; Macdonald, T; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2012 | Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome | Talamonti, M; Galluzzo, M; Chiricozzi, A; Teoli, M; Bavetta, M; Costanzo, A; Chimenti, S | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile